ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

25 hedge funds and large institutions have $1.31M invested in Oramed Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
5
Closed
3
Calls
$265K
Puts
$143K
Net Calls
+$122K
Net Calls Change
-$71K

Top Buyers

1
PNC Financial Services Group
1
PNC Financial Services Group
Pennsylvania
$92K
2
CG
2
Cutler Group
California
$130K
3
Deutsche Bank
3
Deutsche Bank
Germany
$9K
4
DLHL
4
Donald L. Hagan LLC
Florida
$7K
5
JIC
5
Joel Isaacson & Co
New York
$5K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Group One Trading
2
Group One Trading
Illinois
$67K
3
GIM
3
Greylin Investment Management
Virginia
$69K
4
Simplex Trading
4
Simplex Trading
Illinois
$5K
5
PAIM
5
Punch & Associates Investment Management
Minnesota
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
– -$123K -14,364 Closed
PAIM
27
Punch & Associates Investment Management
Minnesota
– -$6.84K -800 Closed
Citigroup
28
Citigroup
New York
– -$1K -73 Closed
1
2